Form 4 for TMDX TransMedics Group, Inc.
Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0000899243-23-006280 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-27 | 2023-02-23 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $16.01 | +35.9K | 50.3K | +250% | +$575.4K |
| DM | 2023-02-27 | 2023-02-23 | TMDX | Khayal Tamer I | Chief Commercial Off | S - Sale+OE | $73.51 | -35.9K | 44.0K | -45% | -$2.64M |
| DM | 2023-02-27 | 2023-02-23 | TMDX | Khayal Tamer I | Chief Commercial Off | M - OptEx | $0.00 | -35.9K | 46.2K | -44% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-23 | M | A | 32,179 | $16.00 | 46,554 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-23 | S | D | 20,000 | $75.15 | 14,375 | D | — | — | (F7) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $75.00 to $75.50, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F8) Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 3 | Common | Common Stock | 2023-02-23 | S | D | 853 | $74.67 | 34,375 | D | — | — | (F6) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $74.07 to $74.90, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 4 | Common | Common Stock | 2023-02-23 | S | D | 777 | $73.55 | 35,228 | D | — | — | (F5) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $73.00 to $73.99, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 5 | Common | Common Stock | 2023-02-23 | S | D | 6,218 | $72.02 | 36,005 | D | — | — | (F4) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $72.00 to $72.95, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 6 | Common | Common Stock | 2023-02-23 | S | D | 1,763 | $71.46 | 42,223 | D | — | — | (F3) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $71.06 to $71.68, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 7 | Common | Common Stock | 2023-02-23 | M | A | 3,751 | $16.14 | 50,305 | D | — | — | |
| 8 | Common | Common Stock | 2023-02-23 | S | D | 6,319 | $70.18 | 43,986 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $70.00 to $70.92, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 9 | Derivative | Stock Option (Right to Buy) | 2023-02-23 | M | D | 32,179 | $0.00 | 8,036 | D | $16.00 · — to 2029-05-01 | 32,179 Common Stock | (F9) The option vests in equal monthly installments over four years beginning on the date of grant, May 1, 2019. |
| 10 | Derivative | Stock Option (Right to Buy) | 2023-02-23 | M | D | 3,751 | $0.00 | 46,249 | D | $16.14 · — to 2030-02-27 | 3,751 Common Stock | (F10) The option vests at a rate of 2.0833% of the total number of shares each month until the option is fully vested on the fourth anniversary of the vesting commencement date, February 27, 2020. |